Financials Krsnaa Diagnostics Limited

Equities

KRSNAA

INE08LI01020

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 12:32:02 18/05/2024 pm IST			5-day change	1st Jan Change
599.2 ^INR	+0.17%		+2.37%	-15.13%

09/04	Krsnaa Diagnostics Forms New Wholly-Owned Subsidiary	MT
13/02	Transcript : Krsnaa Diagnostics Limited, Q3 2024 Earnings Call, Feb 13, 2024

Valuation

Fiscal Period: March	2022	2023	2024	2025	2026
Capitalization ¹	15,344	14,449	19,316	-	-
Enterprise Value (EV) ¹	15,344	14,449	19,316	19,316	19,316
P/E ratio	21.4 x	23.3 x	35.5 x	19.6 x	12.4 x
Yield	-	-	0.33%	0.5%	0.84%
Capitalization / Revenue	3.37 x	2.97 x	3.17 x	2.37 x	1.73 x
EV / Revenue	3.37 x	2.97 x	3.17 x	2.37 x	1.73 x
EV / EBITDA	11.7 x	11.8 x	14.2 x	9.33 x	6.64 x
EV / FCF	-404 x	-22.2 x	-39.7 x	89.8 x	32.1 x
FCF Yield	-0.25%	-4.5%	-2.52%	1.11%	3.12%
Price to Book	2.13 x	1.96 x	2.38 x	2.13 x	1.84 x
Nbr of stocks (in thousands)	31,398	31,398	32,290	-	-
Reference price ²	488.7	460.2	598.2	598.2	598.2
Announcement Date	28/05/22	27/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo	2021	2022	2023	2024	2025	2026
Net sales ¹	-	4,554	4,871	6,102	8,145	11,167
EBITDA ¹	-	1,315	1,223	1,362	2,070	2,908
EBIT ¹	-	900.9	685.2	598.5	1,204	1,910
Operating Margin	-	19.78%	14.07%	9.81%	14.79%	17.11%
Earnings before Tax (EBT) ¹	-	865.1	802	664.5	1,244	1,978
Net income ¹	1,849	683.9	621.1	529.5	956.5	1,516
Net margin	-	15.02%	12.75%	8.68%	11.74%	13.58%
EPS ²	-	22.88	19.78	16.85	30.50	48.30
Free Cash Flow ¹	-	-37.95	-650.6	-486	215	602
FCF margin	-	-0.83%	-13.36%	-7.96%	2.64%	5.39%
FCF Conversion (EBITDA)	-	-	-	-	10.38%	20.7%
FCF Conversion (Net income)	-	-	-	-	22.48%	39.7%
Dividend per Share ²	-	-	-	2.000	3.000	5.000
Announcement Date	03/08/21	28/05/22	27/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales ¹	-	1,226	1,332	1,396	1,608	1,550	1,650
EBITDA ¹	-	294.1	344.8	313.6	403	348	403
EBIT	-	-	-	-	-	186	226
Operating Margin	-	-	-	-	-	12%	13.7%
Earnings before Tax (EBT)	-	-	-	-	-	-	-
Net income ¹	153.4	136.4	189.2	146.4	203.5	146	153.5
Net margin	-	11.12%	14.2%	10.49%	12.66%	9.42%	9.31%
EPS	-	-	-	-	7.400	5.350	5.000
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	09/11/22	13/02/23	27/05/23	12/08/23	-	-	-

¹INR in Million

Estimates

Balance Sheet Analysis

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-	-38	-651	-486	215	602
ROE (net income / shareholders' equity)	-	14.9%	8.73%	7.25%	11.9%	14%
ROA (Net income/ Total Assets)	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-
Book Value Per Share ²	-	229.0	235.0	251.0	280.0	326.0
Cash Flow per Share	-	-	-	-	-	-
Capex ¹	-	1,322	1,414	1,675	1,750	1,500
Capex / Sales	-	29.03%	29.02%	27.45%	21.49%	13.43%
Announcement Date	03/08/21	28/05/22	27/05/23	-	-	-

¹INR in Million²INR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Krsnaa Diagnostics Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

598.2 INR

Average target price

952 INR

Spread / Average Target

+59.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
KRSNAA DIAGNOSTICS LIMITED	-15.13%	23Cr
SONIC HEALTHCARE LIMITED	-16.99%	855.16Cr
RADNET, INC.	+65.23%	424.44Cr
DR. LAL PATHLABS LIMITED	-1.63%	254.16Cr
SYNLAB AG	-10.68%	243.72Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-41.76%	234.52Cr
NEOGENOMICS, INC.	-8.53%	189.01Cr
FLEURY S.A.	-19.29%	155.21Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.61%	123.34Cr
METROPOLIS HEALTHCARE LIMITED	+9.54%	113.05Cr

Medical & Diagnostic Laboratories